Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer

Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer

US Patent 10413538 · Granted Sep 17, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Increasing cancer patient survival time by administration of dithio-containing c2022
Compositions and methods of use of compounds to increase cancer patient survival2016
Increasing cancer patient survival time by administration of dithio-containing c2015
Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethy2014
Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity2014
Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-py2013
Chemoprotective methods2012
Chemoprotective methods and compositions2011
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents2010
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents2010
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents2010
Compounds and methods for reducing undesired toxicity of chemotherapeutic agents2010